How does MRES's PB Ratio compare to its peers?

Insufficient data to calculate MRES's Price-To-Book Ratio vs. peers for valuation analysis.

How does MRES's PB Ratio compare vs other companies in the US Life Sciences Industry?

Insufficient data to calculate MRES's Price-To-Book Ratio vs. industry for valuation analysis.

What is MRES's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MRES's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of MRES when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MRES's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

MRES Stock Overview

Provides biomedical research and analytical services in Montenegro and internationally. More details

MRES fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($37M)

My Notes

Capture your thoughts, links and company narrative

Institute of Biomedical Research Corp. Competitors

Singular Genomics Systems

NasdaqCM:OMIC

US$49.4m

Rapid Micro Biosystems

NasdaqCM:RPID

US$44.8m

Bioqual

OTCPK:BIOQ

US$58.1m

IsoPlexis

NasdaqGS:ISO

US$30.3m

Price History & Performance

Summary of share price highs, lows and changes for Institute of Biomedical Research
Historical stock prices
Current Share Price	US$0.023
52 Week High	US$0.025
52 Week Low	US$0.0001
Beta	0
1 Month Change	210.81%
3 Month Change	369.39%
1 Year Change	161.36%
3 Year Change	161.36%
5 Year Change	5,311.76%
Change since IPO	-99.62%

Recent updates

Shareholder Returns

	MRES	US Life Sciences	US Market
7D	15.6%	0.8%	-2.1%
1Y	161.4%	-0.8%	21.3%

Return vs Industry: MRES exceeded the US Life Sciences industry which returned 0.2% over the past year.

Return vs Market: MRES exceeded the US Market which returned 23.2% over the past year.

Price Volatility

Is MRES's price volatile compared to industry and market?
MRES volatility
MRES Average Weekly Movement	40.4%
Life Sciences Industry Average Movement	9.3%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.8%
10% least volatile stocks in US Market	3.2%

Stable Share Price: MRES's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: MRES's weekly volatility has increased from 29% to 40% over the past year.

About the Company

Founded	Employees	CEO	Website
2010	n/a	Drasko Pekovic	mrescorp.com

Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators.

Institute of Biomedical Research Corp. Fundamentals Summary

How do Institute of Biomedical Research's earnings and revenue compare to its market cap?
MRES fundamental statistics
Market cap	US$36.95m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is MRES overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MRES income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MRES perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 12:50
End of Day Share Price	2025/01/10 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Institute of Biomedical Research Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Institute of Biomedical Research OTCPK:MRES Stock Report